PDCD1 and hepatocellular carcinoma: Of more interest, however, is that this study further examines the predictive role of HAMP in assessing the sensitivity and prognosis of patients with HCC to PD-1 therapy, which is of great significance both in terms of improving effective clinical treatment rates as well as saving healthcare resources.